Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

Rivino, L; Le Bert, N; Gill, US; Kunasegaran, K; Cheng, Y; Tan, DZM; Becht, E; Hansi, NK; Foster, GR; Su, TH; Tseng, TC; Lim, SG; Kao, JH; Newell, EW; Kennedy, PTF; Bertoletti, A

Bertoletti, A (reprint author), Duke NUS Med Sch, Emerging Infect Dis Programme, 8 Coll Rd, Singapore 169857, Singapore.

JOURNAL OF CLINICAL INVESTIGATION, 2018; 128 (2): 668

Abstract

BACKGROUND. The clinical management of chronic hepatitis B virus (HBV) patients is based exclusively on virological parameters that cannot independent......

Full Text Link